-
-
-
-
-
-
-
Grifols announces positive topline phase 3 fibrinogen clinical trial results
-
-
-
-
-
-
-
Grifols to acquire Alkahest to enhance discovery research and development to identify innovative therapies for age-related diseases based upon an understanding of the human plasma proteome
-
-
-
-
-
-
-
Grifols agrees to acquire Hologic's share of NAT donor screening unit for USD 1,850 million
-
-
-
1,155,002 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

